Etidronic acid
Etidronic acid, also known as etidronate, is a bisphosphonate drug.
≈ 1 min read
Etidronic acid. encyclopegia.org, snapshot enwiki-001367568684. /a/etidronic-acid
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Etidronic acid, also known as etidronate, is a bisphosphonate drug. It is non-nitrogenous bisphosphonate. It was patented in 1966 and approved for medical use in 1977. For medicinal purposes, etidronic acid has been obsolete since the early 2010's.
Medical
Etidronic acid is a bisphosphonate once used to strengthen bone, treat osteoporosis, and treat Paget's disease of bone. Bisphosphonates primarily reduce osteoclastic activity, which prevents bone resorption, and thus moves the bone resorption/formation equilibrium toward the formation side and hence makes bone denser in the long run.
Etidronate, unlike other bisphosphonates, also prevents bone calcification. For this reason, other bisphosphonates, such as alendronate, are preferred when fighting osteoporosis. To prevent bone resorption without affecting too much bone calcification, etidronate is administered only for a short time once in a while, for example for two weeks every 3 months.
When given on a continuous basis, say every day, etidronate will altogether prevent bone calcification. This effect may be useful and etidronate was in fact used this way to fight heterotopic ossification. But in the long run, if used on a continuous basis, it will cause osteomalacia.
Synthesis
Etidronic acid can be prepared by reactions of dialkylphosphites and carboxylic acid anhydrides. Other precursors include phosphorus trichloride and phosphorous acid.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1367568684 under CC BY-SA 4.0; modifications have been made.